About IntiQuan
IntiQuan is a Healthcare company based in Basel (Switzerland) founded in 2015, and was acquired by ProductLife Group in October 2024. It operates as a PKPD modeling services are provided to pharmaceutical clients. IntiQuan offers products and services including IQR Tools, IQ Report, IQ NCA, and IQ Desktop. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Pharmacometrics. Its legal entity is IntiQuan AG. Its competitors include InSilicoTrials, Revolution Medicine, CONTINUUM India, Generable and Chrestos and 3 more; 3 of its 8 listed competitors have raised funding.
Company details
IntiQuan was established in 2015 in Basel, Switzerland. Focus is placed on pharmacokinetic and pharmacodynamic (PKPD) modeling within the pharmaceutical and biotechnology sectors. Services encompass quantitative analysis, simulation, and data interpretation to aid drug discovery, development, and regulatory processes. Operations are centered in Switzerland, with support extended to global clients through specialized modeling expertise for clinical trial optimization and decision-making.
- Headquarters Basel, Switzerland
- Stage Acquired
- SectorsHealthcare
- Website intiquan.com
- Acquired by ProductLife Group (Oct 2024)
- Legal Name Intiquan Ag
- Investors
- Acquired byProductLife Group
(Oct 2024)
Products & Services of IntiQuan
IntiQuan offers a comprehensive portfolio of products and services, including IQR Tools, IQ Report, IQ NCA, and IQ Desktop.
R-based environment for efficient PK and PD analyses in drug development.
Generates submission-ready Word reports for analysis results and documentation.
Performs noncompartmental analysis on datasets for pharmacokinetic studies.
Virtual platform for reproducible modeling and simulation tasks in research.
Investors in IntiQuan
IntiQuan has secured backing from 1 investor. Prominent investors backing the company include ProductLife Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Regulatory and pharmacovigilance support is provided for product lifecycles. | 2000 | productlifegroup.com | Suresnes, France |
Investor details for IntiQuan
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of IntiQuan
2 dated milestones of IntiQuan across 9 years, from founding to its latest funding, stage changes and deals.
- Founded IntiQuan is founded.
- Exit Acquired by ProductLife Group.
Competitors of IntiQuan
IntiQuan has 8 listed competitors in our database, 3 of them funded. They include InSilicoTrials, Revolution Medicine, CONTINUUM India, Generable and Chrestos, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| insilicotrials.com | 2016 | Milan, Italy | $3.5M | – | Healthcare simulation services are provided for medical applications worldwide. | |
| revolutionmedicine.com | 2014 | Orlando, United States | – | 181 | Delivers comprehensive pharmacogenomic testing services for personalized medical solutions. | |
| continuumindia.com | 2018 | Chandigarh, India | – | 454 | Offers pharmacovigilance, regulatory, evidence evaluation, and technology solutions to pharma firms. | |
| generable.com | 2016 | New York, United States | $120,000 | – | Precision medicine is delivered via statistical machine learning models. | |
| chrestos.de | 2006 | Essen, Germany | – | 54 | Pharmacokinetic and pharmacodynamic study services are offered by this CRO. | |
| incitehealth.com | 2014 | Doylestown, United States | $330,666 | – | Clinical laboratory specializing in immune system testing and pharmacogenomics services for clinical trials | |
| cognigen.com | 1992 | Buffalo, United States | – | – | Strategic clinical pharmacology and pharmacometric consulting services are provided. | |
| pharmetheus.com | 2012 | Uppsala, Sweden | – | – | Offers pharmacometric services to support efficient and effective drug development processes. |
Detailed competitors of IntiQuan
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of IntiQuan
The website of IntiQuan (intiquan.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 16.9% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as IntiQuan (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Intiquan
Complete news archive for IntiQuan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IntiQuan
IntiQuan was founded in 2015.
IntiQuan is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
IntiQuan was established in 2015 in Basel, Switzerland. Focus is placed on pharmacokinetic and pharmacodynamic (PKPD) modeling within the pharmaceutical and biotechnology sectors. Services encompass quantitative analysis, simulation, and data interpretation to aid drug discovery, development, and regulatory processes. Operations are centered in Switzerland, with support extended to global clients through specialized modeling expertise for clinical trial optimization and decision-making.
IntiQuan's top competitors include InSilicoTrials, Chrestos and Incite Health.
IntiQuan offers IQR Tools, IQ Report, IQ NCA, and IQ Desktop.
IntiQuan has 1 investor. Key investors include ProductLife Group.
IntiQuan operates through Intiquan Ag.
Yes. IntiQuan was acquired by ProductLife Group in October 2024.